CN101129970A - Traditional Chinese medicine for treating metaphase and advanced liver cancer - Google Patents
Traditional Chinese medicine for treating metaphase and advanced liver cancer Download PDFInfo
- Publication number
- CN101129970A CN101129970A CNA2007101317292A CN200710131729A CN101129970A CN 101129970 A CN101129970 A CN 101129970A CN A2007101317292 A CNA2007101317292 A CN A2007101317292A CN 200710131729 A CN200710131729 A CN 200710131729A CN 101129970 A CN101129970 A CN 101129970A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- grams
- rhizoma
- parched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000007270 liver cancer Diseases 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 230000031864 metaphase Effects 0.000 title 1
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 5
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 5
- 239000009526 Fructus Akebiae Substances 0.000 claims abstract description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 4
- 206010023126 Jaundice Diseases 0.000 claims description 4
- 206010000060 Abdominal distension Diseases 0.000 claims description 3
- 241000756943 Codonopsis Species 0.000 claims description 3
- 206010018830 Haematemesis Diseases 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 210000003141 Lower Extremity Anatomy 0.000 claims description 3
- 210000001809 Melena Anatomy 0.000 claims description 3
- 206010030113 Oedema Diseases 0.000 claims description 3
- 206010030302 Oliguria Diseases 0.000 claims description 3
- 241000222640 Polyporus Species 0.000 claims description 3
- 241000131808 Scolopendra Species 0.000 claims description 3
- 210000000582 Semen Anatomy 0.000 claims description 3
- 230000003187 abdominal Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000010271 massa medicata fermentata Substances 0.000 claims description 3
- 229940107666 ASTRAGALUS ROOT Drugs 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241001127714 Amomum Species 0.000 abstract 1
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000036905 Benincasa cerifera Species 0.000 abstract 1
- 235000011274 Benincasa cerifera Nutrition 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000282461 Canis lupus Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000758993 Equisetidae Species 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000008755 Hypericum japonicum Species 0.000 abstract 1
- 210000000826 Nictitating Membrane Anatomy 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 240000005158 Phaseolus vulgaris Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 240000005401 Polyporus umbellatus Species 0.000 abstract 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 210000003813 Thumb Anatomy 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000017423 hawthorn Nutrition 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 206010033799 Paralysis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102100008450 AFP Human genes 0.000 description 1
- 101700014023 AFP Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 210000003228 Bile Ducts, Intrahepatic Anatomy 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 210000003494 Hepatocytes Anatomy 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 230000002559 cytogenic Effects 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
The invention provides a Chinese medicinal capsule for treating late phase liver cancer, wherein the recipe includes Bupleurum root, zedoary, pinellia tuber, dried orange peel, amomum fruit each 12g, Hypericum japonicum Thunb. , raw astragalus root, oldenlandia, dandehon herb each 30g, pilose asiabell root, poria cocos wolf each 20g, white atractylodes rhizome, fructus akebiae each 15g, centipede 2 pieces, haw, medicated leaven, malt each 10g, licorice root 6g, artemisia capillaris thumb, red phaseolus bean each 30g, rhubarb horsetails 6g, poria peel, polyporus umbellatus, oriental water plantain rhizome, waxgourd peel each 30g, notoginseng powder 3g, bletilla tuber 12g, garden burnet root 15g. The Chinese medicament has simplified recipe, easy preparing process and low price.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hepatocarcinoma, particularly a kind of Chinese medicine for the treatment of mid and late liver cancer.
Background technology
Hepatocarcinoma means hepatocyte or the cytogenetic canceration of stones in intrahepatic bile duct.With liver carrying out property enlargement and pain, jaundice is generated heat clinically, and ascites is hemorrhage, and the alpha-fetoglobulin positive etc. is main performance.
At present, when people's paralysis has the mid and late liver cancer disease, in the flourishing city of medical condition, people are hospital treatments, generally all be to use Western medicine or have an injection and treat, and in the small towns, more particularly away from the small towns, outlying village is when people's paralysis has the disease of mid and late liver cancer, because family income is low, living in penury, the locality lacks medical condition, needs expensive travelling expenses to go to the flourishing city of medical condition to go to seek medical advice if want to cure the disease, the medical expense of hospital and medical expenses costliness in addition, people's treatment of often not going sick, the recovery from illness of giving free rein to, therefore some patient has incured loss through delay treatment opportunity.
Summary of the invention
The objective of the invention is to provide a kind of: the Chinese medicine of the treatment mid and late liver cancer that expense is cheap.
The technical scheme that solves its technical problem employing is: the main formula agent: Radix Bupleuri, Rhizoma Curcumae, Rhizoma Pinelliae, Pericarpium Citri Reticulatae, each 12 gram of Fructus Amomi, Herba Hyperici Japonici, Radix Astragali, Herba Hedyotidis Diffusae, each 30 gram of Herba Taraxaci, Radix Codonopsis, each 20 gram of Poria, Rhizoma Atractylodis Macrocephalae (parched), each 15 gram of Fructus Akebiae, 2 of Scolopendras, Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown), each 10 gram of Fructus Hordei Germinatus (parched to brown), Radix Glycyrrhizae 6 grams; Auxiliary prescription: companion jaundice person adds Herba Artemisiae Scopariae, each 30 gram of Semen Phaseoli, Radix Et Rhizoma Rhei 6 grams; Companion's abdominal distention, edema of pair of lower extremities, oliguria person add Cortex Sclerotii Poriae, Polyporus, Rhizoma Alismatis, each 30 gram of Exocarpium Benincasae; Companion's hematemesis, melena person add Radix Notoginseng powder 3 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 12 grams, charred Radix Sanguisorbae 15 grams.
Beneficial effect: owing to adopted such scheme, the material that makes up a prescription in the prescription all uses natural Chinese herbal medicines, adds that then traditional concocting method is made, material is easily got, prescription and preparation method are simple, and preparation medicine expense is cheap, has reached purpose of the present invention.This Chinese herbal medicine compatibility is simple, employed medicine uses natural herbal fully in the pharmaceutical formulation, it is convenient to get, use, manufacture method is simple, it is good to take therapeutic effect, drug price is cheap, can adapt to the people that live in away from small towns, outlying village especially and use, and has people's medical expense of mid and late liver cancer disease cheap to paralysis.
This Chinese herbal medicine is a prescription handed down from one's ancestors, cures mainly mid and late liver cancer.With 300 milliliters of decoctings, Radix Notoginseng powder is taken after mixing it with water, and divides 2 clothes sooner or later, 1 dose of every day, takes continuously 90 days.Use this prescription to treat mid and late liver cancer patient 256 examples, wherein use cure 87 examples a course of treatment, account for 34%; Use cure 93 examples two courses of treatment, account for 36%; Use cure 51 examples three above courses of treatment, account for 20%; Disease controlling 24 examples account for 9%; Readily good therapeutic effect 2 examples account for 1%, and obvious to mid and late liver cancer disease cured rate effect, the patient of readily good therapeutic effect only accounts for 1%, and paralysis person takes in the therapeutic process of this prescription, does not produce untoward reaction.
The specific embodiment
Embodiment 1: the main formula agent: Radix Bupleuri, Rhizoma Curcumae, Rhizoma Pinelliae, Pericarpium Citri Reticulatae, each 12 gram of Fructus Amomi, Herba Hyperici Japonici, Radix Astragali, Herba Hedyotidis Diffusae, each 30 gram of Herba Taraxaci, Radix Codonopsis, each 20 gram of Poria, Rhizoma Atractylodis Macrocephalae (parched), each 15 gram of Fructus Akebiae, 2 of Scolopendras, Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown), each 10 gram of Fructus Hordei Germinatus (parched to brown), Radix Glycyrrhizae 6 grams; Auxiliary prescription: companion jaundice person adds Herba Artemisiae Scopariae, each 30 gram of Semen Phaseoli, Radix Et Rhizoma Rhei 6 grams; Companion's abdominal distention, edema of pair of lower extremities, oliguria person add Cortex Sclerotii Poriae, Polyporus, Rhizoma Alismatis, each 30 gram of Exocarpium Benincasae; Companion's hematemesis, melena person add Radix Notoginseng powder 3 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 12 grams, charred Radix Sanguisorbae 15 grams.
Claims (1)
1. Chinese medicine for the treatment of mid and late liver cancer, it is characterized in that: the main formula agent: Radix Bupleuri, Rhizoma Curcumae, Rhizoma Pinelliae, Pericarpium Citri Reticulatae, each 12 gram of Fructus Amomi, Herba Hyperici Japonici, Radix Astragali, Herba Hedyotidis Diffusae, each 30 gram of Herba Taraxaci, Radix Codonopsis, each 20 gram of Poria, Rhizoma Atractylodis Macrocephalae (parched), each 15 gram of Fructus Akebiae, 2 of Scolopendras, Fructus Crataegi (parched to brown), Massa Medicata Fermentata (parched to brown), each 10 gram of Fructus Hordei Germinatus (parched to brown), Radix Glycyrrhizae 6 grams; Auxiliary prescription: companion jaundice person adds Herba Artemisiae Scopariae, each 30 gram of Semen Phaseoli, Radix Et Rhizoma Rhei 6 grams; Companion's abdominal distention, edema of pair of lower extremities, oliguria person add Cortex Sclerotii Poriae, Polyporus, Rhizoma Alismatis, each 30 gram of Exocarpium Benincasae; Companion's hematemesis, melena person add Radix Notoginseng powder 3 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 12 grams, charred Radix Sanguisorbae 15 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101317292A CN101129970A (en) | 2007-08-29 | 2007-08-29 | Traditional Chinese medicine for treating metaphase and advanced liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101317292A CN101129970A (en) | 2007-08-29 | 2007-08-29 | Traditional Chinese medicine for treating metaphase and advanced liver cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101129970A true CN101129970A (en) | 2008-02-27 |
Family
ID=39127482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101317292A Pending CN101129970A (en) | 2007-08-29 | 2007-08-29 | Traditional Chinese medicine for treating metaphase and advanced liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101129970A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101700386B (en) * | 2009-11-12 | 2011-05-11 | 范先明 | Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
| CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| CN101301337B (en) * | 2008-06-03 | 2011-09-21 | 陈德顺 | Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis |
| CN103751547A (en) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof |
| CN105213613A (en) * | 2015-10-30 | 2016-01-06 | 葛忠 | A kind of Chinese medicine composition of Hepatoma therapy |
| CN113952435B (en) * | 2021-11-05 | 2022-06-17 | 甘肃兰药药业有限公司 | Traditional Chinese medicine composition for adjuvant treatment of liver cancer and preparation method thereof |
-
2007
- 2007-08-29 CN CNA2007101317292A patent/CN101129970A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301337B (en) * | 2008-06-03 | 2011-09-21 | 陈德顺 | Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis |
| CN101700386B (en) * | 2009-11-12 | 2011-05-11 | 范先明 | Traditional Chinese medicine composition resistant to liver cancer and medicine coat thereof |
| CN102058744A (en) * | 2010-11-25 | 2011-05-18 | 代龙 | Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| CN103751547A (en) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof |
| CN105213613A (en) * | 2015-10-30 | 2016-01-06 | 葛忠 | A kind of Chinese medicine composition of Hepatoma therapy |
| CN113952435B (en) * | 2021-11-05 | 2022-06-17 | 甘肃兰药药业有限公司 | Traditional Chinese medicine composition for adjuvant treatment of liver cancer and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101129552A (en) | Traditional Chinese medicine for treating chronic functional constipation | |
| CN101152535A (en) | Traditional Chinese medicine for treating subacute thyroiditis | |
| CN101129771A (en) | Traditional Chinese medicine for treating bradykinesia type constipation | |
| CN101129593A (en) | Traditional Chinese medicine for treating senility habitual constipation | |
| CN101152433A (en) | Traditional Chinese medicine for treating chemotherapy leukocytopenia after mammary cancer operation | |
| CN101152331A (en) | Traditional Chinese medicine for treating Qi asthenia type hemorrhoid hemorrhage | |
| CN101129970A (en) | Traditional Chinese medicine for treating metaphase and advanced liver cancer | |
| CN101129945A (en) | Traditional Chinese medicine for treating diffuse liver cancer | |
| CN101129594A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN101129617A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101130000A (en) | Traditional Chinese medicine for treating postoperative constipation | |
| CN101129966A (en) | Traditional Chinese medicine for treating thyroid hyperfunction companioned with diarrhea | |
| CN101152518A (en) | Traditional Chinese medicine for treating chemotherapy adverse effect after mammary cancer operation | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN101152282A (en) | Traditional Chinese medicine for treating tumefaction of membrum superius after mammary cancer operation | |
| CN101130051A (en) | Traditional Chinese medicine for treating stomach cancer | |
| CN101167893A (en) | Traditional Chinese medicine for treating viral hepatitis | |
| CN101152519A (en) | Traditional Chinese medicine for treating gestational hypertension complex | |
| CN101164611A (en) | Traditional Chinese medicine for treating invasion of lung by cold type pertussis | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
| CN101129967A (en) | Traditional Chinese medicine for treating diabetes diarrhea | |
| CN101152540A (en) | Chinese traditional medicine for treating chronic hepatitis | |
| CN101129893A (en) | Traditional Chinese medicine for treating cervical vertebra disease combined with diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080227 |